Published Clinical research
Psilocybin Mushrooms
Psilocybin-containing mushrooms are a sacred fungi sacrament used for spiritual growth, acceptance of terminal illness, empathy, and enhanced mental health.
July 16, 2021
Frontiers in Psychiatry
Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study
July 13, 2021
Scientific Reports
Associations between lifetime classic psychedelic use and cardiometabolic diseases
June 15, 2021
Irish Journal of Medical Science
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy
February 20, 2021
Journal of Psychopharmacology
Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches
March 25, 2021
Frontiers in Pharmacology
Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness
March 31, 2020
Frontiers in Psychiatry
Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review
February 10, 2020
Scientific Reports
Emotions and brain function are altered up to one month after a single high dose of psilocybin
October 24, 2019
Scientific Reports
Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat
April 23, 2019
PLoS One
Survey of subjective “God encounter experiences”: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT
August 8, 2018
Cell Reports
Psychedelics Promote Structural and Functional Neural Plasticity
September 26, 2018
Journal of Psychopharmacology
The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women
February 20, 2018
Frontiers in Pharmacology
Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
January 17, 2018
Frontiers in Pharmacology
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
June 27, 2018
Journal of Psychopharmacology
High dose psilocybin is associated with positive subjective effects in healthy volunteers
January 7, 2018
Journal of Psychopharmacology
Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression
October 13, 2017
Scientific Reports
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
October 11, 2017
Journal of Psychopharmacology
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors
September 21, 2017
BMJ Open
Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting
July 16, 2017
International Journal of Psychopharmacology
Effect of Psilocybin on Empathy and Moral Decision-Making
November 30, 2016
Journal of Psychopharmacology
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
November 30, 2016
Journal of Psychopharmacology
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
August 30, 2016
Journal of Psychopharmacology
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
January 1, 2016
Current Drug Abuse Reviews
Psilocybin-occasioned Mystical Experiences in the Treatment of Tobacco Addiction
September 28, 2011
Journal of Psychopharmacology
Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness